Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial

Hoffmann S., Schrezenmeier E., Desmarets M., Halleck F., Durrbach A., Peters L., Tremmel A-T., Seidel A., Führer M., Bachmann F., Schrezenmeier J., Greiner J., Körper S., Hofmann H., Ludwig C., Vieweg C., Jahrsdörfer B., Budde K., Schmidt M., Münch J., Joher N., Daguindau E., Grüner B., Brunotte G., Vauchy C., Seifried E., Bradshaw D., Estcourt LJ., Roberts DJ., Toussirot E., Rijnders B., Tiberghien P., Schrezenmeier H.

DOI

10.1016/j.ebiom.2025.105613

Type

Journal article

Publisher

Elsevier BV

Publication Date

2025-03-01T00:00:00+00:00

Volume

113

Pages

105613 - 105613

Total pages

0

Permalink More information Close